Big news! Boehringer Ingelheim has submitted an application to the FDA requesting accelerated approval for idarucizumab, the reversal agent for Pradaxa (dabigatran). See: Boehringer Ingelheim Submits Biologics License Application to FDA for Idarucizumab*, Investigational Specific Reversal Agent for Pradaxa® Additionally, they have submitted for marketing approval by Health Canada and the European Medicines Agency (EMA). See: Boehringer …
Read More
Plan to join us March 28-29, 2015, at the StopAfib.org National Atrial Fibrillation Patient Conference to hear our rock-star cast of afib experts share ways for you to get in rhythm and stay in rhythm. This is a not-to-be-missed event—take a look at who’s speaking! The conference will be held at the Hyatt Regency DFW …
Read More
Here's more good news about the upcoming antidote for Eliquis - see: Positive Results for Factor Xa Inhibitor Antidote: ANNEXA-A
Read More
Today, at the European Society of Cardiology Congress in Barcelona, it was reported that even though 80% of atrial fibrillation patients who should be on anticoagulants (according to their CHA2DS2-VASc score) are on anticoagulants, death rates at one year are still high. Most of those deaths are due to cardiovascular causes. The risk factors predicting …
Read More
Five top U.S. heart centers and StopAfib.org, a leading atrial fibrillation (afib) patient advocacy group, are partnering in the National Alliance of Integrated AFib Centers in order to improve the treatment of afib patients. Learn more at: Top U.S. Heart Treatment Centers, Patient Group, Form Alliance to Improve Irregular Heartbeat Care
Read More
The new 2014 AHA/ACC/HRS Atrial Fibrillation Guidelines were just released at the American College of Cardiology annual conference. In this video interview, Dr. Hugh Calkins discusses what afib patients should know about the new afib guidelines. To watch the video, see: Dr. Hugh Calkins Discusses the New AHA/ACC/HRS Atrial Fibrillation Guidelines — Video Interview
Read More
At the Get in Rhythm, Stay in Rhythm Atrial Fibrillation Patient Conference, world-renowned electrophysiologist Eric N. Prystowsky talked about treatments for atrial fibrillation, including rate control medications and rhythm control medications, as well as use of anticoagulants to prevent afib-related strokes. In addition, Dr. Prystowsky received the first ever “Advocate for Patients” Award from StopAfib.org. …
Read More
Do you want to attend the Get in Rhythm, Stay in Rhythm AF Patient Conference, but just haven’t had time to register? It’s that time! With only a few more days before we have to stop taking registrations (and confirm the numbers with the hotel), and with the discounted hotel room rates expiring as well, …
Read More
ACT (Anti-Coagulation Therapy) Now, a free educational seminar, will be held on October 15, 2013. StopAfib.org founder, Mellanie True Hills, will be one of the panelists. Learn more at: Online educational seminar, ACT (Anti-Coagulation Therapy) Now, to be October 15, 2013
Read More
StopAfib.org participated in a video series for those living with afib. The latest video, The Top Things You Need to Know When Taking an Anticoagulant, was released on September 29 for World Heart Day. To learn more, and watch the video, go to: StopAfib.org Participates in New Video Series About Atrial Fibrillation and Stroke Risk
Read More